IM Cannabis (IMCC) Common Equity (2019 - 2026)
IM Cannabis (IMCC) posted quarterly Common Equity of -$3.7 million for Q1 2026, down 268.97% year-over-year from $2.2 million in Q1 2025, and down 44.14% quarter-over-quarter from -$2.6 million in Q4 2025.
IM Cannabis (IMCC) Common Equity (2019 - 2026) Analysis & Trends
IM Cannabis' Common Equity history runs 8 years deep, the most recent figure standing at -$3.7 million for Q1 2026.
- In Q1 2026, Common Equity fell 268.97% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$3.7 million (down 268.97% YoY), while the FY2025 annual figure was -$2.6 million, down 167.69% from the prior year.
- Common Equity for Q1 2026 stood at -$3.7 million, down from -$2.6 million in the prior quarter.
- The five-year high for Common Equity was $156.6 million in Q1 2022, with the low at -$3.7 million in Q1 2026.
- The 5-year median for Common Equity is $6.2 million (2024), against an average of $25.6 million.
- The sharpest annual moves came in 2025 and 2026: Common Equity climbed 1.31% in 2025, then slumped 268.97% in 2026.
- IM Cannabis' Common Equity stood at $16.7 million in 2022, then slumped by 39.7% to $10.1 million in 2023, then sank by 62.7% to $3.8 million in 2024, then sank by 169.07% to -$2.6 million in 2025, then slumped by 44.14% to -$3.7 million in 2026.
- Business Quant data shows IMCC's Common Equity at -$3.7 million in Q1 2026, -$2.6 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | IM Cannabis | 554,496.00 | -614,474.17 | 1.09 Mn | -4.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.00 Mn |
| Mar 31, 2026 | -3.74 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Sep 30, 2025 | 3.13 Mn |
| Jun 30, 2025 | 2.93 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | 3.75 Mn |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 4.01 Mn |
| Mar 31, 2024 | 6.19 Mn |
| Dec 31, 2023 | 10.06 Mn |
| Sep 30, 2023 | 14.76 Mn |
| Jun 30, 2023 | 16.03 Mn |
| Mar 31, 2023 | 18.16 Mn |
| Dec 31, 2022 | 16.69 Mn |
| Sep 30, 2022 | 42.92 Mn |
| Jun 30, 2022 | 140.82 Mn |
| Mar 31, 2022 | 156.60 Mn |
| Dec 31, 2021 | 162.59 Mn |
| Dec 31, 2020 | 8.51 Mn |